This study identified IL-6 as a crucial cytokine in RBMS1 overexpression, demonstrating its involvement in promoting migration and invasion of cancer cells through IL-6 transactivation and JAK2/STAT3 downstream signaling pathway activation. The gene discussed is IL6; the disease is cancer.